(Q81887452)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18752379%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

review article

1 reference

title

Warfarin pharmacogenetics (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18752379%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

Nita A Limdi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18752379%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

David L Veenstra

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18752379%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

publication date

1 September 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18752379%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18752379%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18752379%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18752379%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

page(s)

1084-1097

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18752379%20AND%20SRC:MED&resulttype=core&format=json

What are the barriers to warfarin use in atrial fibrillation?: Development of a questionnaire.

13 January 2020

cites work

1 reference

12 December 2020

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

12 December 2020

A method to determine the optimal intensity of oral anticoagulant therapy

1 reference

12 December 2020

Genetic determinants of dose and clinical outcomes in patients receiving oral anticoagulants

1 reference

12 December 2020

Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs

1 reference

12 December 2020

A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity.

1 reference

12 December 2020

A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin resistance

1 reference

12 December 2020

Association of Vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population

1 reference

12 December 2020

A prospective, randomized pilot trial of model-based warfarin dose initiation using CYP2C9 genotype and clinical data

1 reference

12 December 2020

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

1 reference

12 December 2020

VKORCI haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation

1 reference

12 December 2020

Apolipoprotein E (APOE) and warfarin dosing in an Italian population

1 reference

12 December 2020

Warfarin pharmacogenetics: CYP2C9 and VKORC1 genotypes predict different sensitivity and resistance frequencies in the Ashkenazi and Sephardi Jewish populations.

1 reference

12 December 2020

Several-fold increase in risk of overanticoagulation by CYP2C9 mutations

1 reference

12 December 2020

VKORC1 gene variations are the major contributors of variation in warfarin dose in Japanese patients.

1 reference

12 December 2020

Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM).

1 reference

12 December 2020

Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

1 reference

12 December 2020

Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin

1 reference

12 December 2020

Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans

1 reference

12 December 2020

Warfarin sensitivity related to CYP2C9, CYP3A5, ABCB1 (MDR1) and other factors.

1 reference

12 December 2020

Pharmacology and pharmacogenetics of warfarin and other coumarins when used with supplements.

1 reference

12 December 2020

VKORC1 and CYP2C9 Genotypes and Phenprocoumon Anticoagulation Status: Interaction Between both Genotypes Affects Dose Requirement

1 reference

12 December 2020

Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans

1 reference

12 December 2020

Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

12 December 2020

Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype.

1 reference

12 December 2020

Main haplotypes and mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population: a retrospective analysis of case records

1 reference

12 December 2020

Allelic variants in the CYP2C9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in Italians.

1 reference

12 December 2020

CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study.

1 reference

12 December 2020

Genetic modulation of oral anticoagulation with warfarin

1 reference

12 December 2020

Interindividual variability in sensitivity to warfarin--Nature or nurture?

1 reference

12 December 2020

Genetic-based dosing in orthopedic patients beginning warfarin therapy.

1 reference

12 December 2020

Combined genetic profiles of components and regulators of the vitamin K-dependent gamma-carboxylation system affect individual sensitivity to warfarin

1 reference

12 December 2020

Comparison of anticoagulation clinic patient outcomes with outcomes from traditional care in a family medicine clinic

1 reference

12 December 2020

A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin.

1 reference

12 December 2020

Influence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin

1 reference

12 December 2020

A rapid-ACCE review of CYP2C9 and VKORC1 alleles testing to inform warfarin dosing in adults at elevated risk for thrombotic events to avoid serious bleeding

1 reference

12 December 2020

Warfarin and cytochrome P450 2C9 genotype: possible ethnic variation in warfarin sensitivity

1 reference

12 December 2020

Genetic Susceptibility to Nonsteroidal Anti-Inflammatory Drug–Related Gastroduodenal Bleeding: Role of Cytochrome P450 2C9 Polymorphisms

1 reference

12 December 2020

Factors influencing warfarin dose requirements in African-Americans

1 reference

12 December 2020

Apolipoprotein E genotype and warfarin dosing among Caucasians and African Americans

1 reference

12 December 2020

Warfarin Response and Vitamin K Epoxide Reductase Complex 1 in African Americans and Caucasians

1 reference

12 December 2020

Complications of oral anticoagulant therapy: bleeding and nonbleeding, rates and risk factors

1 reference

12 December 2020

Acenocoumarol stabilization is delayed in CYP2C93 carriers

1 reference

12 December 2020

Effects of cytochrome P450 2C9 polymorphisms on phenprocoumon anticoagulation status

1 reference

12 December 2020

VKORC1 and CYP2C9 genotypes and acenocoumarol anticoagulation status: interaction between both genotypes affects overanticoagulation.

1 reference

12 December 2020

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

1 reference

12 December 2020

APOE genotype makes a small contribution to warfarin dose requirements.

1 reference

12 December 2020

Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group

1 reference

12 December 2020

A warfarin-dosing model in Asians that uses single-nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9.

1 reference

12 December 2020

The influence of sequence variations in factor VII, gamma-glutamyl carboxylase and vitamin K epoxide reductase complex genes on warfarin dose requirement

1 reference

12 December 2020

Prospective study of warfarin dosage requirements based on CYP2C9 and VKORC1 genotypes

1 reference

12 December 2020

Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment.

1 reference

12 December 2020

The underutilization of cardiac medications of proven benefit, 1990 to 2002

1 reference

12 December 2020

A vitamin K epoxide reductase complex subunit-1 (VKORC1) mutation in a patient with vitamin K antagonist resistance

1 reference

12 December 2020

Effect of polymorphisms in the cytochrome P450 CYP2C9 gene on warfarin anticoagulation

1 reference

12 December 2020

Polymorphisms in vitamin K-dependent gamma-carboxylation-related genes influence interindividual variability in plasma protein C and protein S activities in the general population

1 reference

12 December 2020

Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements.

1 reference

12 December 2020

The cost-effectiveness of warfarin pharmacogenomics

1 reference

12 December 2020

The frequency and effects of cytochrome P450 (CYP) 2C9 polymorphisms in patients receiving warfarin

1 reference

12 December 2020

Warfarin and the vitamin K-dependent gamma-carboxylation system

1 reference

12 December 2020

Common genetic variants of microsomal epoxide hydrolase affect warfarin dose requirements beyond the effect of cytochrome P450 2C9.

1 reference

12 December 2020

Quality assessment of anticoagulation dose management: comparative evaluation of measures of time-in-therapeutic range

1 reference

12 December 2020

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.

1 reference

12 December 2020

Pharmacodynamic resistance to warfarin associated with a Val66Met substitution in vitamin K epoxide reductase complex subunit 1.

1 reference

12 December 2020

Influence of CYP2C9 Genotype on warfarin dose among African American and European Americans

1 reference

12 December 2020

Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

1 reference

12 December 2020

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

1 reference

12 December 2020

Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients

1 reference

12 December 2020

Identification and functional characterization of a new CYP2C9 variant (CYP2C9*5) expressed among African Americans

1 reference

12 December 2020

Pharmacogenetics of warfarin: current status and future challenges

1 reference

12 December 2020

Relative impact of covariates in prescribing warfarin according to CYP2C9 genotype

1 reference

12 December 2020

CYP2C9 allelic variants: ethnic distribution and functional significance

1 reference

12 December 2020

Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions

1 reference

12 December 2020

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen

1 reference

12 December 2020

An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation

1 reference

12 December 2020

Underutilization of anticoagulation therapy in chronic atrial fibrillation

1 reference

12 December 2020

Proceedings of the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: evidence-based guidelines

1 reference

12 December 2020

Human P450 metabolism of warfarin

1 reference

12 December 2020

Effective anticoagulation therapy: defining the gap between clinical studies and clinical practice.

1 reference

12 December 2020

Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation

1 reference

12 December 2020

A new vitamin K epoxide reductase complex subunit-1 (VKORC1) mutation in a patient with decreased stability of CYP2C9 enzyme

1 reference

12 December 2020

Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation

1 reference

12 December 2020

The c.-1639G > A polymorphism of the VKORC1 gene is a major determinant of the response to acenocoumarol in anticoagulated patients

1 reference

12 December 2020

Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity.

1 reference

12 December 2020

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

1 reference

12 December 2020

Common VKORC1 and GGCX polymorphisms associated with warfarin dose

1 reference

12 December 2020

1173C>T polymorphism in VKORC1 modulates the required warfarin dose

1 reference

12 December 2020

Discovery of new potentially defective alleles of human CYP2C9.

1 reference

12 December 2020

Genetic determinants of response to warfarin during initial anticoagulation

1 reference

12 December 2020

Identification of the gene for vitamin K epoxide reductase

1 reference

12 December 2020

Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation

1 reference

12 December 2020

Identifiers

DOI

10.1592/PHCO.28.9.1084

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18752379%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18752379%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

PubMed publication ID

18752379

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18752379%20AND%20SRC:MED&resulttype=core&format=json